These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25072839)

  • 41. Differentiation of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis by specific PCR amplification of the RPS0 intron.
    del Pilar Vercher M; García Martínez JM; Cantón E; Pemán J; Gómez García MM; Gómez EV; del Castillo Agudo L
    Int J Med Microbiol; 2011 Aug; 301(6):531-5. PubMed ID: 21570908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
    Ferroni A; Suarez S; Beretti JL; Dauphin B; Bille E; Meyer J; Bougnoux ME; Alanio A; Berche P; Nassif X
    J Clin Microbiol; 2010 May; 48(5):1542-8. PubMed ID: 20237092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Bader O; Weig M; Taverne-Ghadwal L; Lugert R; Gross U; Kuhns M
    Clin Microbiol Infect; 2011 Sep; 17(9):1359-65. PubMed ID: 20946411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex.
    Treviño-Rangel Rde J; González JG; González GM
    Med Mycol; 2013 Apr; 51(3):331-5. PubMed ID: 22928925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology.
    Szabó Z; Szilágyi J; Tavanti A; Kardos G; Rozgonyi F; Bayegan S; Majoros L
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):283-8. PubMed ID: 19394787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) and Bayesian phylogenetic analysis to characterize Candida clinical isolates.
    Angeletti S; Lo Presti A; Cella E; Dicuonzo G; Crea F; Palazzotti B; Dedej E; Ciccozzi M; De Florio L
    J Microbiol Methods; 2015 Dec; 119():214-22. PubMed ID: 26551247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of clinical yeasts by Vitek MS system compared with API ID 32 C.
    Durán-Valle MT; Sanz-Rodríguez N; Muñoz-Paraíso C; Almagro-Moltó M; Gómez-Garcés JL
    Med Mycol; 2014 May; 52(4):342-9. PubMed ID: 24782106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry to detect emerging pathogenic Candida species.
    Santos C; Lima N; Sampaio P; Pais C
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):304-8. PubMed ID: 21855250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of capacity to detect ability to form biofilm in Candida parapsilosis sensu stricto strains by MALDI-TOF MS.
    Mlynáriková K; Šedo O; Růžička F; Zdráhal Z; Holá V; Mahelová M
    Folia Microbiol (Praha); 2016 Nov; 61(6):465-471. PubMed ID: 27068413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities.
    Ge YP; Boekhout T; Zhan P; Lu GX; Shen YN; Li M; Shao HF; Liu WD
    Med Mycol; 2012 Jan; 50(1):56-66. PubMed ID: 21728755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.
    Gago S; García-Rodas R; Cuesta I; Mellado E; Alastruey-Izquierdo A
    Virulence; 2014 Feb; 5(2):278-85. PubMed ID: 24193303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Genotypic identification and distribution patterns of Candida parapsilosis complex species (C.parapsilosis sensu stricto, C.metapsilosis and C.orthopsilosis) isolated from clinical samples].
    Cebeci Güler N; Tosun I; Bayramoğlu G; Buruk K; Aydın F
    Mikrobiyol Bul; 2011 Oct; 45(4):723-8. PubMed ID: 22090303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.
    Martí-Carrizosa M; Sánchez-Reus F; March F; Coll P
    Scand J Infect Dis; 2014 Jun; 46(6):454-61. PubMed ID: 24762093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species.
    Garcia-Effron G; Canton E; Pemán J; Dilger A; Romá E; Perlin DS
    J Clin Microbiol; 2011 Sep; 49(9):3257-61. PubMed ID: 21795509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Candida glabrata complex species: use of Vitek MS
    Hou X; Xiao M; Chen SC; Kong F; Wang H; Fan X; Zhao YP; Xu YC
    Future Microbiol; 2018 May; 13():645-657. PubMed ID: 29745727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
    Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
    FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis.
    Lattif AA; Mukherjee PK; Chandra J; Swindell K; Lockhart SR; Diekema DJ; Pfaller MA; Ghannoum MA
    Int J Med Microbiol; 2010 Apr; 300(4):265-70. PubMed ID: 19932053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units.
    Pulcrano G; Roscetto E; Iula VD; Panellis D; Rossano F; Catania MR
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):2919-28. PubMed ID: 22644055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of CHROMagar Candida Medium, Biochemical Methods--API ID32C and VITEK 2 Compact and Two MALDI-TOF MS Systems for Candida spp. Identification.
    Stefaniuk E; Baraniak A; Fortuna M; Hryniewicz W
    Pol J Microbiol; 2016; 65(1):111-4. PubMed ID: 27282002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals.
    Sendid B; Ducoroy P; François N; Lucchi G; Spinali S; Vagner O; Damiens S; Bonnin A; Poulain D; Dalle F
    Med Mycol; 2013 Jan; 51(1):25-32. PubMed ID: 22703164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.